Moolec Science SA Logo

Moolec Science SA

Uses Molecular Farming to grow animal proteins in plants for food, feed, and supplement industries.

MLEC | NDAQ

Overview

Corporate Details

ISIN(s):
LU2559000059 (+1 more)
LEI:
Country:
United States of America
Address:
17, BOULEVARD F.W. RAIFFEISAN, LUXEMBOURG
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Moolec Science SA is a science-based ingredient company that utilizes a proprietary Molecular Farming technology to produce animal proteins and other valuable nutritional ingredients in plants. By introducing animal genes into the genomes of crops like soybeans and safflower, the company uses plants as bioreactors to create sustainable and scalable food ingredients. Its key products include bioengineered soybeans containing porcine proteins (Piggy Sooy™) and safflower oil with a high concentration of gamma-linolenic acid (GLASO™). Moolec aims to provide cost-effective, traceable, and functional ingredients for the food, animal feed, and dietary supplement industries, offering an alternative to traditional animal-based production systems.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Moolec Science SA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Moolec Science SA

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Moolec Science SA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Renascience Inc. Logo
Develops innovative drugs and AI-powered medical devices for aging and hereditary diseases.
Japan 4889
Rentracks CO.,LTD. Logo
A pay-per-performance ad network with a closed ASP and comprehensive web consulting services.
Japan 6045
Replimune Group, Inc. Logo
Clinical-stage biotech developing oncolytic immunotherapies to treat a broad range of cancers.
United States of America REPL
ReproCELL Incorporated Logo
Offers stem cell tech, gene editing & drug discovery services for preclinical/clinical research.
Japan 4978
RESEARCH FRONTIERS INC Logo
Develops and licenses smart glass tech for instant light, UV, and heat control.
United States of America REFR
Resolute Holdings Management, Inc. Logo
Asset management firm acquiring and operationally enhancing companies for long-term growth.
United States of America RHLD
Develops RNA aptamer therapeutics for ophthalmology, pain, fibrosis, and other unmet medical needs.
Japan 4591
Rise Consulting Group, Inc. Logo
Execution-focused consulting for strategy and digital transformation, specializing in JP-CN markets.
Japan 9168
ROQUEFORT THERAPEUTICS PLC Logo
Developing first-in-class, pre-clinical medicines for hard-to-treat cancers.
United Kingdom ROQ
ROSS GROUP PLC Logo
A holding company in liquidation, formerly providing supply chain management & technology solutions.
United Kingdom RGP

Talk to a Data Expert

Have a question? We'll get back to you promptly.